Cargando…
TRIPS, the Doha Declaration and increasing access to medicines: policy options for Ghana
There are acute disparities in pharmaceutical access between developing and industrialized countries. Developing countries make up approximately 80% of the world's population but only represent approximately 20% of global pharmaceutical consumption. Among the many barriers to drug access are th...
Autores principales: | Cohen, JC, Gyansa-Lutterodt, M, Torpey, K, Esmail, LC, Kurokawa, G |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1334179/ https://www.ncbi.nlm.nih.gov/pubmed/16336685 http://dx.doi.org/10.1186/1744-8603-1-17 |
Ejemplares similares
-
TRIPS, the Doha declaration and paragraph 6 decision: what are the remaining steps for protecting access to medicines?
por: Kerry, Vanessa Bradford, et al.
Publicado: (2007) -
Supporting the Development of Evidence-Informed Policy Options: An Economic Evaluation of Hypertension Management in Ghana
por: Gad, Mohamed, et al.
Publicado: (2020) -
Trends in Compulsory Licensing of Pharmaceuticals Since the Doha Declaration: A Database Analysis
por: Beall, Reed, et al.
Publicado: (2012) -
Situational analysis of antibiotic use and resistance in Ghana: policy and regulation
por: Yevutsey, Saviour Kwame, et al.
Publicado: (2017) -
Integrating Global and National Knowledge to Select Medicines for Children: The Ghana National Drugs Programme
por: Sinclair, David, et al.
Publicado: (2013)